MedTrace Logo

Cocaine Abuse and Attention Deficit Disorder - 3

NCT00000268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Bupropion

Sponsors & Collaborators

  • New York State Psychiatric Institute

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Herbert Kleber, M.D. · New York State Psychiatric Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1995-05-31
Completion
1998-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000268 on ClinicalTrials.gov